VIRTUAL EXHIBIT HALL

Learning Objectives

By the end of this event, participants will be able to :

  • Discuss the results and practical implications of the latest clinical trial results in the management of patients with type 1 and type 2 diabetes
  • Utilize lifestyle and pharmacological approaches to the prevention and treatment of diabetes complications, including cardiovascular disease, chronic kidney disease and neuropathy
  • Evaluate the integration of novel and emerging therapies for diabetes and associated metabolic disorders into clinical practice

Plenary Session Day 1: Friday, May 1, 2020

Evidence Behind Dietary Intervention in Diabetes in 2020

John Sievenpiper, MD

Following this session, participants will be able to:

  • Review current and evolving nutritional approaches for the prevention and management of diabetes

Update on CVOTs: Is it time for a new approach?

Alice Y.Y. Cheng, MD

Following this session, participants will be able to:

  • Discuss the benefits and limitations of current CVOT designs and consider modifications that could improve the clinical value and efficiency of future trials

Severe Hypoglycemia in Canada

Rémi Rabasa-Lhoret, MD

Following this session, participants will be able to:

  • Discuss recent registry data on the frequency, attitudes, consequences and care of severe hypoglycemia in Canada

Update on CKD and Diabetes: Treatment and mechanisms

Jordan Weinstein, MD

Following this session, participants will be able to:

  • Examine current and emerging therapeutic targets and the clinical trial evidence in diabetic kidney disease

Diabetes Drugs for Those Without Diabetes: Where are we now and what does the future hold?

Jacob A. Udell, MD

Following this session, participants will be able to:

  • Explore the rationale and evidence for the application of antidiabetic drugs beyond their use in patients with diabetes

WORKSHOPS

Workshop 1: A Practical Approach to Popular Diets in Diabetes and Obesity

Wendy Graham, RD, CDE

Following this session, participants will be able to:

  • Discuss the pros and cons of contemporary diets for the nutritional management of people with metabolic disorders

Workshop 2: Is There Really a Need for the Newer Insulins?

Irene Hramiak, MD

Following this session, participants will be able to:

  • Examine the benefits and limitations of newer insulins relative to conventional insulins

Workshop 3: Not the Usual Diabetes (cystic fibrosis, DM post solid organ transplant, DM post islet transplant)

Peter Senior, MD

Following this session, participants will be able to:

  • Explore the pathophysiology and treatment of cystic fibrosis-related diabetes
  • Review the unique aspects of diabetes management in the context of solid organ transplantation
  • Discuss the latest developments in pancreatic islet transplantation in type 1 diabetes

Plenary Session Day 2: Saturday, May 2, 2020

Limb Preservation: #ActAgainstAmputation

Zaina Albalawi, MD

Following this session, participants will be able to:

  • Navigate how to act against preventable amputations in diabetes
  • Discover the power of social media strategies to heighten awareness about limb preservation in diabetes

Screening for Cardiovascular Disease: What you need to know

James Stone, MD

Following this session, participants will be able to:

  • Review key elements of cardiovascular disease screening, prevention and management in patients with diabetes

Beyond A1C, Time in Range and Glucose Variability: Is it time for a new gold standard?

Ilana Halperin, MD

Following this session, participants will be able to:

  • Discuss new parameters beyond conventional glucose metrics for assessing and monitoring glycemic control

Update on Novel Therapies in Diabetes: What’s hot and what’s new?

Ronald Goldenberg, MD

Following this session, participants will be able to:

  • Review cutting edge and emerging therapeutic targets and treatments for the management of diabetes

Debate: SGLT2i Should Be Used as Adjunctive Therapy for Patients With Type 1 Diabetes

Ian Blumer, MD
Bruce Perkins, MD

Following this session, participants will be able to:

  • Explore the role of adjunctive therapies to insulin in the contemporary management of type 1 diabetes

Subscribe to get the latest updates